Zobrazeno 1 - 10
of 16
pro vyhledávání: '"Sita Nookala"'
Autor:
Travis T. Sims, Molly B. El Alam, Tatiana V. Karpinets, Stephanie Dorta-Estremera, Venkatesh L. Hegde, Sita Nookala, Kyoko Yoshida-Court, Xiaogang Wu, Greyson W. G. Biegert, Andrea Y. Delgado Medrano, Travis Solley, Mustapha Ahmed-Kaddar, Bhavana V. Chapman, K. Jagannadha Sastry, Melissa P. Mezzari, Joseph F. Petrosino, Lilie L. Lin, Lois Ramondetta, Anuja Jhingran, Kathleen M. Schmeler, Nadim J. Ajami, Jennifer Wargo, Lauren E. Colbert, Ann H. Klopp
Publikováno v:
Communications Biology, Vol 4, Iss 1, Pp 1-10 (2021)
Travis Sims and Molly El Alam et al. show that diversity of gut microbiota is associated with a favorable response to chemoradiation for cervical cancer and use flow cytometry to show that patients with high microbiome diversity had increased tumor i
Externí odkaz:
https://doaj.org/article/c76ee253ea0f4e5b85dab20f72cbe758
Autor:
Stephanie Dorta-Estremera, Venkatesh L. Hegde, Ravaen B. Slay, Rachel Sun, Ananta V. Yanamandra, Courtney Nicholas, Sita Nookala, Gloria Sierra, Michael A. Curran, K. Jagannadha Sastry
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-12 (2019)
Abstract Background The US is experiencing an epidemic of HPV+ oropharyngeal cancers (OPC), the rates and burden of which now exceed that for cervical cancer. Immunotherapy targeting programmed death 1 (PD-1) on tumor-infiltrating lymphocytes and/or
Externí odkaz:
https://doaj.org/article/53572afbfb9b4310ad7268f36c515187
Autor:
Peiying Yang PhD, Patrea R. Rhea BS, Tara Conway BS, Sita Nookala BS, Venkatesh Hegde PhD, Mihai Gagea DVSc, Nadim J. Ajami PhD, Sean L. Harribance, Jewel Ochoa MA, Jagannadha K. Sastry PhD, Lorenzo Cohen PhD
Publikováno v:
Integrative Cancer Therapies, Vol 19 (2020)
Studies have demonstrated that purported biofield therapy emitted from humans can inhibit the proliferation of cancer cells and suppress tumor growth in various cancers. We explored the effects of biofield therapy on tumor growth in the Lewis lung ca
Externí odkaz:
https://doaj.org/article/63c79d4c9cfa463680f2bef60e089416
Autor:
Alexandre Reuben, Ramez Kouzy, Venkatesh Hegde, Lauren E. Colbert, Andrea Y. Delgado Medrano, Kathleen M. Schmeler, Jianhua Zhang, Cassidy Papso, Albert C. Koong, Erica Lynn, Bhavana V. Chapman, Eugene J. Koay, Bruce D. Minsky, Tatiana Karpinets, Kyoko Yoshida-Court, Greyson Biegert, Lilie L. Lin, Travis T. Sims, Sita Nookala, Molly B. El Alam, Prajnan Das, Lois M. Ramondetta, Aparna Mitra, Adilene Olvera, Amir A. Jazaeri, Minsoo Kim, Cullen M. Taniguchi, K.V.H. Sastry, Ann H. Klopp, Mustapha Ahmed-Kaddar, Ananta V. Yanamandra, Jennifer A. Wargo, Anuja Jhingran, Rohit Kavukuntla, Daniel Lin, Andrew Futreal, Julianna Edwards, Xiaogang Wu, Patricia J. Eifel, Emma B. Holliday, Jingyan Yue, Stephanie Dorta-Estremera, Geena Mathew, Travis Solley
Human papillomavirus (HPV) infection causes 600,000 new cancers worldwide each year. HPV-related cancers express the oncogenic proteins E6 and E7, which could serve as tumor-specific antigens. It is not known whether immunity to E6 and E7 evolves dur
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::67deb303b796d5d18c81d2493a3901ab
https://doi.org/10.21203/rs.3.rs-105933/v1
https://doi.org/10.21203/rs.3.rs-105933/v1
Autor:
Vipul K. Singh, Abhishek Mishra, Ekramy E. Sayedahmed, Jin Wang, Min Chen, David H. Canaday, K. Jagannadha Sastry, Stephanie Dorta-Estremera, Chinnaswamy Jagannath, Arshad Khan, Sita Nookala, Suresh K. Mittal
Publikováno v:
Cell Reports Medicine
Summary Although the BCG vaccine offers partial protection, tuberculosis remains a leading cause of infectious disease death, killing ∼1.5 million people annually. We developed mucosal vaccines expressing the autophagy-inducing peptide C5 and mycob
Autor:
Ann H. Klopp, Andrea Y. Delgado Medrano, Lauren E. Colbert, Tatiana Karpinets, Nadim J. Ajami, Bhavana V. Chapman, Anuja Jhingran, Melissa Paola Mezzari, Kyoko Yoshida-Court, Greyson Biegert, Molly B. El Alam, Jennifer A. Wargo, Kathleen M. Schmeler, Lilie L. Lin, Stephanie Dorta-Estremera, Lois M. Ramondetta, Travis Solley, Mustapha Ahmed-Kaddar, Travis T. Sims, Venkatesh Hegde, Joseph F. Petrosino, K. Jagannadha Sastry, Xiaogang Wu, Sita Nookala
Publikováno v:
Communications Biology
Communications Biology, Vol 4, Iss 1, Pp 1-10 (2021)
Communications Biology, Vol 4, Iss 1, Pp 1-10 (2021)
Diversity of the gut microbiome is associated with higher response rates for cancer patients receiving immunotherapy but has not been investigated in patients receiving radiation therapy. Additionally, current studies investigating the gut microbiome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b6e11a232369e60be3caee6f903f592
Autor:
Sita Nookala, Lauren E. Colbert, Stephanie Dorta-Estremera, Megan Mikkelson, Ann H. Klopp, K. Jagannadha Sastry, Melissa Paola Mezzari, Travis Solley, Jianhua Zhang, P. Andrew Futreal, Joseph F. Petrosino, Tatiana Karpinets, Andrea Y. Delgado Medrano
Publikováno v:
Cancer prevention research (Philadelphia, Pa.). 13(12)
Antibiotics affect microbial diversity in the gut, leading to dysbiosis and impaired immunity. However, the impact of antibiotics on microbial communities at other sites, such as vagina is less understood. It is also not clear whether changes induced
Autor:
Lauren E. Colbert, Jagannadha K. Sastry, Stephanie Dorta-Estremera, Ann H. Klopp, Andrea Delgado, Sita Nookala, Ananta V. Yanamandra, Guojun Yang, Lin L. Lilie, Patricia J. Eifel, Anuja Jhingran, Megan Mikkelson, James W. Welsh, Kathleen M. Schmeler
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 102:593-600
Purpose Radiation therapy has direct cytotoxic effects on tumor-infiltrating lymphocytes, but it also has immune stimulatory effects that increase immune cell infiltration. The dynamics of these competing effects on immune cells at the site of the tu
Autor:
Michael A. Curran, Sita Nookala, Gloria Sierra, Ananta V. Yanamandra, K. Jagannadha Sastry, Stephanie Dorta-Estremera, Ravaen B Slay, Venkatesh Hegde, Courtney Nicholas, Rachel Sun
Publikováno v:
Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-12 (2019)
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-12 (2019)
Background The US is experiencing an epidemic of HPV+ oropharyngeal cancers (OPC), the rates and burden of which now exceed that for cervical cancer. Immunotherapy targeting programmed death 1 (PD-1) on tumor-infiltrating lymphocytes and/or its ligan
Autor:
Venkatesh L Hegde, Gloria Sierra, Sita Nookala, Ananta Yanamandra, Madison O’Hara, Jagannadha K Sastry
Publikováno v:
The Journal of Immunology. 206:29.11-29.11
High-risk type human papillomaviruses (HPV) are the underlying cause of >5% of all cancers including cervical and Head & Neck cancers in which virus-encoded E6/E7 oncoproteins serve as tumor-specific antigens. Despite the success of prophylactic HPV